Free Trial
NASDAQ:VINC

Vincerx Pharma (VINC) Stock Price, News & Analysis

Vincerx Pharma logo
$0.04 -0.01 (-18.78%)
As of 08/8/2025 03:45 PM Eastern

About Vincerx Pharma Stock (NASDAQ:VINC)

Key Stats

Today's Range
$0.03
$0.05
50-Day Range
$0.03
$0.06
52-Week Range
$0.03
$17.00
Volume
183,586 shs
Average Volume
603,834 shs
Market Capitalization
$208.31 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.00
Consensus Rating
Buy

Company Overview

Vincerx Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

VINC MarketRank™: 

Vincerx Pharma scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vincerx Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vincerx Pharma has received no research coverage in the past 90 days.

  • Read more about Vincerx Pharma's stock forecast and price target.
  • Earnings Growth

    Earnings for Vincerx Pharma are expected to grow in the coming year, from ($10.00) to ($6.40) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vincerx Pharma is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vincerx Pharma is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vincerx Pharma has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Vincerx Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the outstanding shares of Vincerx Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    Vincerx Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Vincerx Pharma does not currently pay a dividend.

  • Dividend Growth

    Vincerx Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the outstanding shares of Vincerx Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    Vincerx Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vincerx Pharma this week, compared to 1 article on an average week.
  • Search Interest

    8 people have searched for VINC on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Vincerx Pharma to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vincerx Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.60% of the stock of Vincerx Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.02% of the stock of Vincerx Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vincerx Pharma's insider trading history.
Receive VINC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter.

VINC Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Vincerx Pharma, Inc. (VINC) - Yahoo Finance
See More Headlines

VINC Stock Analysis - Frequently Asked Questions

Vincerx Pharma's stock was trading at $5.2560 on January 1st, 2025. Since then, VINC shares have decreased by 99.2% and is now trading at $0.0398.

Vincerx Pharma, Inc. (NASDAQ:VINC) issued its quarterly earnings results on Thursday, August, 8th. The company reported ($1.00) EPS for the quarter, beating analysts' consensus estimates of ($3.40) by $2.40.

Vincerx Pharma shares reverse split before market open on Tuesday, January 28th 2025.The 1-20 reverse split was announced on Thursday, January 23rd 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of VINC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vincerx Pharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Jabil (JBL) and CymaBay Therapeutics (CBAY).

Company Calendar

Last Earnings
8/08/2024
Today
8/09/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VINC
CIK
1796129
Fax
N/A
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$40.00
Low Price Target
$40.00
Potential Upside/Downside
+100,402.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($20.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-248.33%
Return on Assets
-132.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.17
Quick Ratio
2.17

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.50 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
5,234,000
Free Float
1,891,000
Market Cap
$208.31 thousand
Optionable
Not Optionable
Beta
1.71
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:VINC) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners